Bellevue Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.5M | Sell |
|
|||||
|
2025
Q1 | $70.4M | Sell |
|
|||||
|
2024
Q4 | $81.3M | Sell |
|
|||||
|
2024
Q3 | $74.8M | Sell |
|
|||||
|
2024
Q2 | $116M | Buy |
|
|||||
|
2024
Q1 | $105M | Buy |
|
|||||
|
2023
Q4 | $77.7M | Sell |
|
|||||
|
2023
Q3 | $71M | Sell |
|
|||||
|
2023
Q2 | $97.9M | Sell |
|
|||||
|
2023
Q1 | $86.1M | Sell |
|
|||||
|
2022
Q4 | $79.4M | Buy |
|
|||||
|
2022
Q3 | $84.8M | Buy |
|
|||||
|
2022
Q2 | $96.1M | Buy |
|
|||||
|
2022
Q1 | $107M | Sell |
|
|||||
|
2021
Q4 | $119M | Buy |
|
|||||
|
2021
Q3 | $98.5M | Sell |
|
|||||
|
2021
Q2 | $92.2M | Hold |
|
|||||
|
2021
Q1 | $74.5M | Buy |
|
|||||
|
2020
Q4 | $75.4M | Sell |
|
|||||
|
2020
Q3 | $66.1M | Buy |
|
|||||
|
2020
Q2 | $54.7M | Buy |
|
|||||
|
2020
Q1 | $44.1M | Buy |
|
|||||
|
2019
Q4 | $47.3M | Buy |
|
|||||
|
2019
Q3 | $42.8M | Buy |
|
|||||
|
2019
Q2 | $32.1M | Buy |
|
|||||
|
2019
Q1 | $31M | Buy |
|
|||||
|
2018
Q4 | $24.2M | Sell |
|
|||||
|
2018
Q3 | $44.1M | Buy |
|
|||||
|
2018
Q2 | $29.9M | Buy |
|
|||||
|
2018
Q1 | $27.5M | Buy |
|
|||||
|
2017
Q4 | $21.2M | Sell |
|
|||||
|
2017
Q3 | $22.5M | Buy |
|
|||||
|
2017
Q2 | $22.5M | Buy |
|
|||||
|
2017
Q1 | $11.8M | Hold |
|
|||||
|
2016
Q4 | $11.7M | Buy |
|
|||||
|
2016
Q3 | $10.2M | Buy |
|
|||||
|
2016
Q2 | $6.78M | Sell |
|
|||||
|
2016
Q1 | $6.44M | Buy |
|